BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin F, Wang H, Yuan F, Ding Y. Platelet-Rich Plasma Combined with Alendronate Reduces Pain and Inflammation in Induced Osteoarthritis in Rats by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway. Biomed Res Int 2020;2020:8070295. [PMID: 33062701 DOI: 10.1155/2020/8070295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Schulze-Tanzil G. Experimental Therapeutics for the Treatment of Osteoarthritis. J Exp Pharmacol 2021;13:101-25. [PMID: 33603501 DOI: 10.2147/JEP.S237479] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Boffa A, Salerno M, Merli G, De Girolamo L, Laver L, Magalon J, Sánchez M, Tischer T, Filardo G. Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models. Knee Surg Sports Traumatol Arthrosc 2021. [PMID: 34341845 DOI: 10.1007/s00167-021-06659-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Belenska-Todorova L, Lambova SN, Stoyanova S, Georgieva E, Batsalova T, Moten D, Kolchakova D, Dzhambazov B. Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis. Biomedicines 2021;9:1017. [PMID: 34440221 DOI: 10.3390/biomedicines9081017] [Reference Citation Analysis]